Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

CBST 62.64 +0.06 (0.10%)
price chart
Analyst Update: EMC Corporation, Teva Pharmaceutical Industries Ltd (ADR ...
Meanwhile, among the equities in focus are tech issue EMC Corporation (NYSE:EMC), as well as drug makers Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Cubist Pharmaceuticals Inc (NASDAQ:CBST), which have all attracted analyst ...
Related articles »  
Active Biotech Stocks in Concerns- MannKind Corporation (NASDAQ:MNKD ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) [Trend Analysis] has second quarter 2014 earnings (excluding special items) of 23 cents per share dropped well short of the Zacks Consensus anticipates of 37 cents due to lesser than anticipated revenues.
Hot Stocks - Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), MannKind. (NASDAQ ...  Markets Insider
Related articles »  
Cubist Pharmaceuticals Inc.: Cubist Reports Second Quarter 2014 Financial ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the second quarter ended June 30, 2014.
Cubist Reports Second Quarter 2014 Financial Results  Wall Street Journal
Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales
Related articles »  
Cubist Pharmaceuticals (CBST) Posts Quarterly Earnings Results, Beats ...
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) posted its quarterly earnings results on Tuesday. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.01 by $0.22, AnalystRatings.
Cubist Pharmaceuticals (CBST) Scheduled to Post Earnings on Tuesday
Cubist Pharmaceuticals, Inc (NASDAQ:CBST) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in ...
Cubist Pharmaceuticals Q2 14 Earnings Conference Call At 5:00 PM ET
Cubist Pharmaceuticals Q2 14 Earnings Conference Call At 5:00 PM ET. By RTT News, July 22, 2014, 03:00:00 PM EDT. A A A. Vote up. loading.
Cubist Pharmaceuticals's Buy Rating Reaffirmed at Jefferies Group (CBST)
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST)'s stock had its �buy� rating reaffirmed by research analysts at Jefferies Group in a report released on Monday.
Cubist Pharmaceuticals's "Positive" Rating Reaffirmed at Aegis (CBST)
Cubist Pharmaceuticals Inc logo Cubist Pharmaceuticals (NASDAQ:CBST)'s stock had its �positive� rating reiterated by equities researchers at Aegis in a research report issued on Monday.
Top Decliners in Focus: Unisys Corporation (UIS), CONMED Corporation ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) fell more than 5 percent in the current trading session after JMP Securities lowered its ratings for the biopharmaceutical company from �Outperform� to �Market Perform� in a research report released on 23rd of July.
Cubist Pharmaceuticals Becomes Oversold (CBST)
In trading on Thursday, shares of Cubist Pharmaceuticals Inc. (NASD: CBST) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $63.0001 per share.
Related articles »